抗生素
青霉素
药物开发
自然(考古学)
业务
投资(军事)
风险分析(工程)
药品
重症监护医学
医学
生化工程
药理学
工程类
生物
微生物学
古生物学
政治
政治学
法学
作者
Andriy Luzhetskyy,Stefan Pelzer,Andreas Bechthold
出处
期刊:Current opinion in investigational drugs
[Current Drugs Ltd.]
日期:2007-08-01
卷期号:8 (8): 608-613
被引量:31
摘要
One reason for the current crisis in antibiotic development is the low return on investment, which is intrinsic to anti-infective drug development. Despite this, smaller pharmaceutical companies are attempting to address the medical need for new antibiotics. Natural products have played a major role in antibiotic drug discovery since 1941 when penicillin was introduced to the market, and currently natural products are again the most important source for promising drug candidates. This review discusses novel methods and technologies that will increase the success rate for identifying novel antibiotics from natural sources.
科研通智能强力驱动
Strongly Powered by AbleSci AI